Becton, Dickinson and Company
IndexS&P 500 P/E45.79 EPS (ttm)5.38 Insider Own0.44% Shs Outstand284.66M Perf Week3.74%
Market Cap69.34B Forward P/E18.50 EPS next Y13.31 Insider Trans-2.25% Shs Float282.12M Perf Month11.41%
Income1.54B PEG24.10 EPS next Q2.66 Inst Own90.90% Short Float / Ratio0.91% / 1.77 Perf Quarter-2.32%
Sales18.87B P/S3.67 EPS this Y3.70% Inst Trans-1.98% Short Interest2.57M Perf Half Y-4.84%
Book/sh88.81 P/B2.77 EPS next Y11.53% ROA3.20% Target Price263.08 Perf Year3.45%
Cash/sh3.60 P/C68.39 EPS next 5Y1.90% ROE6.80% 52W Range215.90 - 277.29 Perf YTD0.42%
Dividend3.64 P/FCF103.65 EPS past 5Y3.10% ROI5.20% 52W High-11.96% Beta0.61
Dividend %1.48% Quick Ratio0.60 Sales past 5Y9.30% Gross Margin44.90% 52W Low13.08% ATR5.47
Employees77000 Current Ratio1.00 Sales Q/Q-1.80% Oper. Margin12.00% RSI (14)59.72 Volatility2.40% 2.32%
OptionableYes Debt/Eq0.64 EPS Q/Q102.10% Profit Margin9.00% Rel Volume0.48 Prev Close246.21
ShortableYes LT Debt/Eq0.55 EarningsNov 10 BMO Payout44.10% Avg Volume1.45M Price244.13
Recom2.40 SMA204.94% SMA506.30% SMA200-1.43% Volume211,066 Change-0.84%
Jul-11-22Downgrade Citigroup Neutral → Sell $265 → $235
Jun-24-22Upgrade Wells Fargo Equal Weight → Overweight $275
Mar-18-22Resumed Raymond James Mkt Perform
Mar-02-22Resumed BofA Securities Neutral $290
Dec-08-21Downgrade Piper Sandler Overweight → Neutral $285 → $260
Aug-06-21Downgrade JP Morgan Overweight → Neutral $265
May-25-21Initiated Barclays Equal Weight $270
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $297
Dec-15-20Downgrade Wells Fargo Overweight → Equal Weight $265
Jul-09-20Upgrade Barclays Equal Weight → Overweight $300
Show Previous Ratings
Dec-04-22 07:00AM
Nov-30-22 06:00AM
Nov-26-22 06:00AM
Nov-22-22 06:01AM
Nov-18-22 07:01AM
04:15PM Loading…
Nov-15-22 04:15PM
Nov-13-22 08:30AM
Nov-12-22 08:26AM
Nov-11-22 08:00AM
Nov-10-22 11:16AM
06:36AM Loading…
Nov-09-22 04:06PM
Nov-07-22 11:10AM
Nov-03-22 10:00AM
Nov-02-22 09:30AM
Nov-01-22 05:55PM
Oct-31-22 08:30AM
Oct-30-22 09:00AM
09:00AM Loading…
Oct-26-22 09:00AM
Oct-22-22 09:01AM
Oct-18-22 12:35PM
Oct-14-22 09:01AM
Oct-13-22 04:15PM
Oct-11-22 01:52PM
Oct-10-22 09:00AM
Oct-07-22 05:12PM
Oct-06-22 03:17PM
Oct-04-22 09:45AM
Oct-03-22 10:00AM
Oct-02-22 09:01AM
Sep-29-22 06:48AM
Sep-28-22 09:02AM
Sep-27-22 06:50AM
Sep-26-22 06:50AM
Sep-24-22 10:02AM
Sep-21-22 10:07AM
Sep-20-22 10:00AM
Sep-14-22 02:22PM
Sep-13-22 08:32AM
Sep-07-22 05:09PM
Sep-06-22 11:01PM
Sep-03-22 08:13AM
Aug-31-22 03:38PM
Aug-30-22 03:11PM
Aug-25-22 04:10PM
Aug-24-22 04:15PM
Aug-22-22 05:00PM
Aug-19-22 04:50PM
Aug-18-22 09:28AM
Aug-15-22 02:41PM
Aug-11-22 07:29AM
Aug-09-22 10:23AM
Aug-08-22 08:46AM
Aug-04-22 12:28PM
Aug-03-22 08:25AM
Aug-02-22 04:53PM
Aug-01-22 10:43AM
Jul-29-22 07:46AM
Jul-28-22 10:03AM
Jul-27-22 09:19AM
Jul-26-22 04:15PM
Jul-25-22 11:40AM
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goette RolandEVP and President, EMEANov 16Option Exercise74.944,617345,99814,896Nov 18 08:41 AM
Polen Thomas E JrChairman, CEO and PresidentAug 15Option Exercise167.9115,0002,518,65043,878Aug 17 07:19 AM
Hickey DavidEVP & President, Life SciencesAug 15Sale265.00475125,8753,331Aug 17 07:21 AM
Polen Thomas E JrChairman, CEO and PresidentAug 15Sale265.139,5002,518,73528,878Aug 17 07:19 AM
Khichi Samrat S.EVP and General CounselAug 09Option Exercise100.3626,8152,691,27220,254Aug 11 04:24 PM
Polen Thomas E JrExecutive Vice PresidentAug 09Option Exercise147.683,825564,87632,703Aug 11 04:23 PM
Polen Thomas E JrExecutive Vice PresidentAug 09Sale260.001,652429,52028,878Aug 11 04:23 PM
Khichi Samrat S.EVP and General CounselAug 09Sale260.449,1852,392,1415,928Aug 11 04:24 PM
Khichi Samrat S.EVP and General CounselAug 08Sale260.447,2951,899,9105,928Aug 11 04:24 PM
Spoerel Thomas JVP Controller & Chief Acct OffJun 07Option Exercise147.681,026151,5202,070Jun 09 10:32 AM
Spoerel Thomas JVP Controller & Chief Acct OffJun 07Sale260.00443115,1801,058Jun 09 10:32 AM
Hickey DavidEVP & President, Life SciencesMay 06Sale256.00475121,6003,806May 10 03:16 PM
Larson Betty DEVP HR & CHROFeb 25Option Exercise188.1146,6588,776,83416,117Feb 28 03:58 PM
Larson Betty DEVP HR & CHROFeb 25Sale271.9014,3743,908,2915,872Feb 28 03:58 PM
Fraser ClaireDirectorFeb 08Sale271.70841228,50021,556Feb 10 10:17 AM
Conroy AlexandreEVP of Integrated Supply ChainFeb 03Option Exercise134.7312,7871,722,79334,047Feb 07 10:42 AM
Conroy AlexandreEVP of Integrated Supply ChainFeb 03Sale270.166,4101,731,72621,260Feb 07 10:42 AM
Larson Betty DEVP HR & CHRODec 16Option Exercise97.1489386,7469,554Dec 17 09:41 AM
Larson Betty DEVP HR & CHRODec 16Sale255.003,341851,9555,872Dec 17 09:41 AM
Spoerel Thomas JVP Controller & Chief Acct OffDec 07Sale250.0023358,2501,079Dec 09 08:09 AM